View Document Preview and Link Document Date: 2015-02-25 17:06:41 Open Document File Size: 408,63 KB Share Result on Facebook
Company Blyth / / Country United States / / IndustryTerm administered neuraminidase inhibitor product / otitis media / antiviral products / investigational products / / MedicalCondition gastric stasis / nose infections / muscular dystrophy / lower respiratory tract disease / COPD / severe influenza disease / Hurt / peramivir-resistant influenza virus infection / headache / ear infections / complicated influenza / bronchitis / Confirmed Influenza / mild febrile respiratory illness / nausea / patient’s disease / influenza virus infection / influenza illness / progressive illness / laboratory-confirmed influenza / septic shock / uncomplicated illness / acute uncomplicated influenza / Renal Disease / currently circulating influenza A / diarrhea / Peramivir Influenza / severe influenza / sinusitis / influenza virus / otitis media / secondary bacterial pneumonia / metabolic disorders / illness / complicated illness / Influenza / severe and prolonged illness / older respiratory disease / seizure disorders / both influenza A / asthma / Oseltamivir Influenza / spinal cord injury / HIV infection / acute lung injury / suspected influenza / cerebral palsy / pneumonia / older underlying respiratory disease / mental retardation / hypertension / respiratory failure / oseltamivir-resistant virus infection / Zanamivir Influenza COPD / critically ill influenza / B Allergic reactions / prescription influenza / chronic obstructive pulmonary disease / influenza A H1N1 / ESRD / influenza A / stroke / predominant influenza / uncomplicated influenza / fever / allergy / viral infections / parainfluenza virus / vomiting / throat infections / S. aureus / virus infection / diabetes mellitus / influenza viruses / sickle cell disease / chronic care facilities / delirium / epilepsy / inflammatory damage / dizziness / cough / renal failure / disorders / influenza B / / MedicalTreatment Chemo / vaccination / mechanical ventilation / immunosuppression / Chemoprophylaxis / extracorporeal membrane oxygenation / Dialysis / renal replacement therapy / / Organization CDC Influenza Division / Advisory Committee on Immunization Practices / U.S. Food and Drug Administration / American Academy of Pediatrics / Committee of the WHO Consultation / / / Position Harper / / Product Tamiflu / Relenza / / ProvinceOrState Manitoba / / Region South East Asia / / Technology Diagnostic Tests / PDF / Dialysis / / URL http / SocialTag 
Influenza Antiviral Medications: Summary for Clinicians Table 1. Antiviral Medications Recommended for Treatment and Chemoprophylaxis of Influenza